approved

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

4 weeks ago

SGS ACHIEVES RECOGNITION AS AN APPROVED LEAF MARQUE CERTIFICATION BODY

MUMBAI, India, Nov. 22, 2024 /PRNewswire/ -- SGS in India is proud to announce that we are approved by LEAF…

1 month ago

SGS ACHIEVES RECOGNITION AS AN APPROVED LEAF MARQUE CERTIFICATION BODY

MUMBAI, India, Nov. 22, 2024 /PRNewswire/ -- SGS in India is proud to announce that we are approved by LEAF…

1 month ago

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

1 month ago

Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in…

1 month ago

IDEX Biometrics – Approved Prospectus – 13 Nov 2024

Reference is made to the stock exchange announcement issued by IDEX Biometrics ASA (the “Company”) on 17 September 2024 regarding…

1 month ago

ALK licenses rights to neffy, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS…

1 month ago

ALK licenses rights to neffy, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS…

1 month ago